MEIP


2 “Strong Buy” Penny Stocks That Could Rally All the Way to $10

Out on Wall Street, one group of stocks divides investors into either fans or critics. Penny stocks, or tickers that trade for less …

MEI Pharma Presents Positive Preclinical Data For Cancer Drug Voruciclib

MEI Pharma announced positive preclinical data for its orally administered drug, voruciclib. Voruciclib blocks CDK9, a cyclin-dependent kinase (CDK) inhibitor and hinders growth …

MEI Pharma (MEIP) Stock Takes a Hit but This Analyst Keeps the Faith

Investors of MEI Pharma (MEIP) trudged off to the 4th of July celebrations in a downbeat mood. In last week’s final session, shares …

Billionaire Ken Griffin Pulls the Trigger on These 3 Penny Stocks

Penny stocks, they divide market watchers like no other. Some investors steer clear of these tickers going for less than $5 apiece, as …

Oppenheimer Sees 232% Upside for MEI Pharma Inc (MEIP); Here’s Why

Oppenheimer analyst Leah R. Cann initiated coverage on shares of MEI Pharma Inc (NASDAQ:MEIP) with an Outperform rating and $6.

Stock Update (NASDAQ:MEIP): MEI Pharma Inc and Helsinn Group Report Prolongation of Survival Results from Phase 2 Clinical Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia

MEI Pharma, Inc. (NASDAQ:MEIP) and Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, announced final results from a Phase …

Company Update (NASDAQ:MEIP): MEI Pharma Inc Reports Fiscal Year 2016 Results

MEI Pharma Inc (NASDAQ:MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today reported results for its fiscal year …

Stock Update (NASDAQ:MEIP): MEI Pharma Inc and Helsinn Group Enter Strategic Agreement for the Development and Commercialization of Pracinostat

MEI Pharma Inc (NASDAQ:MEIP), an oncology company focused on the clinical development of novel therapies for cancer and Helsinn, a Swiss pharmaceutical group focused on …

Wedbush Top Analyst Remains Sidelined on MEI Pharma Inc (MEIP) Despite Receiving Breakthrough Therapy Designation; Here’s Why

MEI Pharma Inc (NASDAQ:MEIP) just received Breakthrough Therapy Designation for its key pipeline drug pracinostat, anti-tumor molecule inhibitor that combined with azacitidine treats …

Company Update (NASDAQ:MEIP): MEI Pharma Inc Announces New Clinical Data from First-in-Human Study of ME-401

MEI Pharma Inc (NASDAQ:MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced new clinical data from a …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts